-
PPM-18 for NF-κB/iNOS Inhibition: Applied Workflows & Insigh
2026-06-11
Leverage PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) for precise inhibition of inducible nitric oxide synthase in immune modulation and sepsis models. This guide reveals optimized protocols, troubleshooting strategies, and cross-study applications for robust NF-κB pathway research.
-
PLAC1 as a Prognostic Target in Clear Cell Renal Cell Carcin
2026-06-11
This study identifies PLAC1 as a key prognostic biomarker and molecular target in clear cell renal cell carcinoma (ccRCC), demonstrating that its inhibition reduces tumor progression. High-throughput virtual screening revealed small molecules capable of downregulating PLAC1, offering new directions for targeted therapy and biomarker-driven drug development.
-
Eltanexor Inhibits Wnt/β-Catenin to Suppress Colorectal Tumo
2026-06-10
This study demonstrates that Eltanexor (KPT-8602), a selective XPO1 inhibitor, effectively suppresses colorectal cancer progression by modulating Wnt/β-catenin signaling and reducing COX-2 expression. The findings support XPO1 as a promising chemopreventive target and provide preclinical evidence for the use of Eltanexor in genetically high-risk colorectal cancer models.
-
Aclacinomycin A: Applied Workflows for DNA Damage and Apopto
2026-06-10
Aclacinomycin A (Aclarubicin) offers unmatched precision for modeling DNA damage and apoptosis in cancer research, thanks to its dual topoisomerase inhibition and robust caspase activation. This guide distills the latest mechanistic insights, workflow enhancements, and troubleshooting strategies, transforming bench protocols with reproducible, quantifiable cellular stress readouts.
-
Ibrexafungerp (MK 3118): Antifungal Activity at Acidic Vagin
2026-06-09
Ibrexafungerp (MK 3118) is a first-in-class oral triterpenoid antifungal active against Candida species, including fluconazole-resistant isolates. Its efficacy is maintained in acidic environments, making it particularly suitable for vulvovaginal candidiasis. Robust in vitro and in vivo data support its clinical adoption.
-
Cytochalasin D as an Actin Polymerization Inhibitor: Applied
2026-06-09
Cytochalasin D is transforming cellular uptake and cancer biology research through its potent inhibition of actin polymerization. This article outlines practical workflows, troubleshooting strategies, and cross-domain applications—anchored by new insights on nanoparticle-cell interactions in ocular models.
-
Imipramine in Autophagy & Apoptosis Assays: Advanced Protoco
2026-06-08
Imipramine, a classic tricyclic antidepressant, is emerging as a versatile research tool for autophagy modulation and apoptosis induction in oncology and neuroimmune studies. This article delivers bench-proven workflows, troubleshooting insights, and data-driven tips, bridging lipidomic findings to experimental design with APExBIO’s research-grade Imipramine.
-
Paeoniflorin Shifts Tmem176b+ Macrophage Polarization in Liv
2026-06-08
This study reveals that paeoniflorin mitigates hepatic ischemia-reperfusion injury by promoting the polarization of Tmem176b+ macrophages from pro-inflammatory to reparative phenotypes. Single-cell RNA sequencing and depletion experiments clarify the essential role of these macrophages in mediating paeoniflorin’s protective effects, offering new insights for immune modulation strategies in liver transplantation.
-
Mycophenolic Acid: Dehydrogenase Inhibitor in Immune Assays
2026-06-07
Mycophenolic acid is a gold-standard dehydrogenase inhibitor enabling precise modulation of immune cell metabolism in whole-blood stimulation assays. Recent standardized protocols unlock robust, reproducible workflows for immunometabolism research—now refined with troubleshooting insights and advanced comparative strategies.
-
Clodronate Liposomes: Optimizing In Vivo Macrophage Depletio
2026-06-06
Clodronate Liposomes from APExBIO empower researchers to dissect macrophage function via targeted in vivo depletion, supporting advanced studies of immune modulation and tumor microenvironment manipulation. This guide offers actionable protocol enhancements, troubleshooting strategies, and evidence-driven insights to maximize reproducibility and experimental clarity.
-
Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling
2026-06-05
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables efficient, high-yield fluorescent RNA probe synthesis for applications such as in situ hybridization and Northern blotting, where sensitive detection is required. It is not validated for diagnostic, therapeutic, or clinical workflows, and should be used strictly in research settings.
-
Ceramides Drive Pro-viral Autophagy in Fish Nodavirus Infect
2026-06-05
This study uses lipidomics to reveal that ceramide accumulation is a key pro-viral factor during red-spotted grouper nervous necrosis virus (RGNNV) infection, driving autophagy to promote viral replication. The results not only clarify the mechanistic role of sphingolipid metabolism in viral pathogenesis but also point to potential intervention strategies targeting ceramide flux.
-
Morin: Mechanistic Innovation for Translational Pathway Rese
2026-06-04
This article explores Morin’s integrated mechanistic profile and translational utility, offering strategic guidance for researchers navigating the intersection of inflammation, mitochondrial dysfunction, and advanced assay design. It synthesizes evidence from cellular, metabolic, and disease-modeling contexts, contextualizes Morin’s unique biochemical features, and sets a visionary agenda for next-generation neuro- and cardioprotective research, with special attention to the challenges and opportunities in complex clinical syndromes such as neuroleptic malignant syndrome.
-
Acacetin Regulates Mitophagy–Pyroptosis Axis in IVDD Therapy
2026-06-04
This study reveals that Duhuo Jisheng decoction, via its active compound acacetin, alleviates intervertebral disc degeneration by modulating the MAPK1/HMOX1 axis to inhibit nucleus pulposus cell pyroptosis. These findings clarify a new regulatory pathway linking mitophagy and pyroptosis, providing a mechanistic basis for targeted interventions in degenerative disc disease.
-
Annexin V-APC/7-AAD Apoptosis Kit: Precision Cell Death Anal
2026-06-03
The Annexin V-APC/7-AAD Apoptosis Kit empowers researchers to rapidly distinguish apoptotic from necrotic cells in complex biological contexts, streamlining experimental workflows with its one-step, dual-color detection system. Its precision and reliability are invaluable for cancer immunology and translational cell death research.